Vir Biotechnology firmó un acuerdo con Gilead de tres candidatos el 14 de octubre de 2026. Para Vir Biotechnology s

En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.

En Yahoo Finance, obtienes cotizaciones de acciones gratuitas, noticias actualizadas, recursos de gestión de carteras, datos de mercados internacionales, interacción social y tasas hipotecarias que te ayudarán a gestionar tu vida financiera.

Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results

Find the latest Vir Biotechnology, Inc. (VIR) stock quote, history, news and other vital information to help you with your stock trading and investing.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Vir Biotechnology has seen sharp swings over the past few years, which puts fresh focus on a simple question for anyone looking at the stock today: Does the current share price line up with what the business is generating from its sales? Over the last 5 years, the share price has fallen 75.2%, which puts a lot of weight on whether the current valuation still fits the company’s revenue base. The new collaboration with Gilead on dual masked T cell engagers, along with fast track status for...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

El acuerdo con Gilead ofrece acciones de Vir Biotechnology hasta 135 millones de dólares por adelantado. Tres candidatos deben f

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Vir Biotechnology announces a Gilead cancer collaboration with US$90 million upfront and contingent milestones for three discovery-stage candidates.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.